Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Hamad Alam
Rectal Adenocarcinoma
New Delhi
Hamad’s struggle reached a terrifying peak in 2018 while traveling back to Delhi from a cou…
Patient Name
Acute Recurrent Pancreatitis
Kotdwar, Uttarakhand.
Shilpi’s struggle began suddenly during her 10th-grade school break, when she felt a sharp …
Anurag Goyal
Investment Banker
New Delhi
Anurag’s struggle began suddenly in the midnight of September 2010, when he experienced exc…
Sumit Kumar
Pancreas Divisum with secondary Chronic Pancreatitis
Dehradun, Uttarakhand
Sumit suffered from Pancreas Divisum, a congenital anomaly where the two pancreatic ducts (the ve…
Aviral Saxena
Chronic Pancreatitis with Secondary Diabetes
Dehradun, Uttarakhand
Aviral’s journey began in November 2022 while he was actively working as a freelancer. The …
Rajeev Sharma
Chronic Pancreatitis
Dehradun, Uttarakhand
Rajeev’s journey began with mild symptoms in 2009, potentially following a physical encount…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Transformation of Copper into therapeutic mineral complex following principles of Rasa Shastra
Rasa Shastra, an Ayurvedic branch, transforms toxic substances into safe therapeutics. A compound using Copper, Mercury, Sulphur, Luffa echinata, Clitoria ternatea, and lemon juice was effective in treating pancreatic disorders. The 2015-17 study developed standard procedures and analyzed the compound, revealing new mineral forms and no free metals. This demonstrates the potential of traditional methods in safely converting metals into effective treatments.
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up
A 47-year-old diabetic male with high-risk AML-M3 relapsed after multiple chemotherapy treatments. In 1997, he opted for a pilot Ayurvedic study and was treated with Navajeevan, Kamadudha Rasa, and Keharuba Pisti. He achieved complete remission and has remained disease-free for 13 years without side effects from the alternative treatment.
Acute Promyelocytic Leukemia: 37 Years Long Ongoing Survival in a de novo Patient with Metal-Based Ayurvedic Treatment
Acute promyelocytic leukemia (APML) is a subtype of leukemia marked by anemia, infections, and bleeding. It is diagnosed through bone marrow tests and the PML-RARα fusion gene. Recent treatments with ATRA and arsenic trioxide have improved survival rates, but challenges like side effects and relapses remain. A 1982 case of a patient who survived 37 years without standard treatment suggests potential alternative therapies.
Relevance of metal based Ayurvedic formulations in the management of recurrent acute/ chronic pancreatitis
This study reports on 250 cases of Recurrent Acute Pancreatitis (RAP) and Chronic Pancreatitis (CP) treated with an Ayurvedic herbo-mineral formulation, along with a balanced diet and lifestyle changes. Significant improvement was seen in patients who completed the treatment.
Scientific validated approach for application of Mandura bhasma A review
Mandura (iron rust) is purified and calcined in Ayurveda to create Mandura Bhasma, used for conditions like spleen and liver enlargement, jaundice, oedema, and anemia. Our study found that Prak-20 aligns with the classical dose schedule for Mandura Bhasma.
Response to Ayurvedic therapy in the treatment of migraine without aura
A study on 204 migraine patients using an Ayurvedic Treatment Protocol (AyTP) showed 35.2% had complete relief, 35.2% had mild episodes without medication, and 70.5% experienced reduced pain frequency and intensity. The preliminary results suggest the AyTP may be effective, though the study's design limits firm conclusions.